Analgesics in New Zealand

Date: November 30, 2017
Pages: 20
Price:
US$ 990.00
Publisher: Euromonitor International Ltd
Report type: Strategic Report
Delivery: E-mail Delivery (PDF)
ID: A327AE5B821EN
Leaflet:

Download PDF Leaflet

In 2017 analgesics experienced similar current value growth to 2016. The main story in 2017 was the launch of chewable ibuprofen targeted towards children. Due to the stagnant birth rate, the launch by GlaxoSmithKline Consumer Healthcare New Zealand targeted children (rather than infants); in particular, the peak birth group of babies born over 2007/2008, which are now nearing 10 years old. Over the review period, a number of submissions to get paediatric analgesics switched from pharmacy-only t...

Euromonitor International's Analgesics in New Zealand report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2012-2016, allowing you to identify the sectors driving growth. Forecasts to 2021 illustrate how the market is set to change.

Product coverage: Systemic Analgesics, Topical Analgesics/Anaesthetic.

Data coverage: market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
  • Get a detailed picture of the Analgesics market;
  • Pinpoint growth sectors and identify factors driving change;
  • Understand the competitive environment, the market’s major players and leading brands;
  • Use five-year forecasts to assess how the market is predicted to develop.
Euromonitor International has over 40 years' experience of publishing market research reports, business reference books and online information systems. With offices in London, Chicago, Singapore, Shanghai, Vilnius, Dubai, Cape Town, Santiago, Sydney, Tokyo and Bangalore and a network of over 800 analysts worldwide, Euromonitor International has a unique capability to develop reliable information resources to help drive informed strategic planning.
Headlines
Prospects
Younger Consumers Are Sought for A Mature Category
Certain Analgesics Are Reviewed
Fast-acting Formulations Remain Paramount
Competitive Landscape
Multinationals Dominate
Domestic Companies Remain in the Picture
Private Label and Cheaper Brands Are Expected To Dampen Growth
Category Data
  Table 1 Sales of Analgesics by Category: Value 2012-2017
  Table 2 Sales of Analgesics by Category: % Value Growth 2012-2017
  Table 3 Sales of Topical Analgesics/Anaesthetic by Format: % Value 2012-2017
  Table 4 NBO Company Shares of Analgesics: % Value 2013-2017
  Table 5 LBN Brand Shares of Analgesics: % Value 2014-2017
  Table 6 Forecast Sales of Analgesics by Category: Value 2017-2022
  Table 7 Forecast Sales of Analgesics by Category: % Value Growth 2017-2022
Executive Summary
Consistent Growth Overall
Age Segmentation Continues
Hybrid Product Developments
Internet Sales Expected To Increase
Modest Growth Expected Over the Forecast Period
Market Indicators
  Table 8 Consumer Expenditure on Health Goods and Medical Services: Value 2012-2017
  Table 9 Life Expectancy at Birth 2012-2017
Market Data
  Table 10 Sales of Consumer Health by Category: Value 2012-2017
  Table 11 Sales of Consumer Health by Category: % Value Growth 2012-2017
  Table 12 NBO Company Shares of Consumer Health: % Value 2013-2017
  Table 13 LBN Brand Shares of Consumer Health: % Value 2014-2017
  Table 14 Penetration of Private Label in Consumer Health by Category: % Value 2012-2017
  Table 15 Distribution of Consumer Health by Format: % Value 2012-2017
  Table 16 Distribution of Consumer Health by Format and Category: % Value 2017
  Table 17 Forecast Sales of Consumer Health by Category: Value 2017-2022
  Table 18 Forecast Sales of Consumer Health by Category: % Value Growth 2017-2022
Appendix
OTC Registration and Classification
Vitamins and Dietary Supplements Registration and Classification
Self-medication/self-care and Preventive Medicine
Switches
  Summary 1 OTC: Switches 2016-2017
Sources
  Summary 2 Research Sources












Skip to top


Calming and Sleeping in New Zealand US$ 990.00 Jun, 2015 · 24 pages
Digestive Remedies in New Zealand US$ 990.00 Nov, 2017 · 20 pages
Ear Care in New Zealand US$ 990.00 Jul, 2013 · 28 pages
Emergency Contraception in New Zealand US$ 990.00 Jul, 2013 · 28 pages

Ask Your Question

Analgesics in New Zealand
Company name*:
Contact person*:
Phone/fax*:
Email*:
Request invoice
Your enquiry:
Please click on a Check Box below to confirm you are not a robot: